Teriparatide (Critical Pharmaceuticals)
N/A
Report date: 2022/09/05 20:00:48
Base Information
Drug NameTeriparatide (Critical Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of NottinghamCritical Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNottingham University Hospitals Nhs Trust
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A